Versant Vantage I GP, L.P. — insider trades

Stock trades Versant Vantage I GP, L.P. reported on SEC Form 4 at LVTX LAVA Therapeutics NV, GLUE Monte Rosa Therapeutics, Inc..

• Sep 19, 2025: sold 2,903,403 shares of LVTX LAVA Therapeutics NV ($4.06M)
• Sep 18, 2025: sold 1,684,434 shares of LVTX LAVA Therapeutics NV ($2.50M)
• Oct 29, 2024: sold 157,895 shares of GLUE Monte Rosa Therapeutics, Inc. ($1.49M)